Despite Outcry, Still No Actos Recall in Europe or the US

Defective Drug Lawsuit

Although the trial against Takeda Pharmaceuticals, manufacturers of the controversial diabetes drug, Actos, continues to heat up Food and Drug Administration (FDA) and the European Medicines Agency have not issued recalls of the drug.

Actos

In 2011, citing strong evidence of Actos’s link to bladder cancer, as well as heart failure, France and Germany issued recalls.

Later in 2011, the lawsuits against Takeda Pharmaceuticals were consolidated into one suit, Multidistrict Litigation (MDL) 2299, in the US District Court of Louisiana (Lafayette). Judge Rebecca Doherty presides over the case.

The FDA did issue a stronger warning on the label, called a black box warning. This is the strongest label a drug can receive from the FDA. The European Medicines Agency has not issued a similar warning, although their website lists some of the detrimental side effects of using the drug.

Actos Lawyers

For more information on a potential recall, please continue to check the Strom Law Blog. The Strom Law Firm, LLC, has experienced lawyers who can help you if you or a loved one have been diagnosed with bladder cancer, congenital heart failure, or liver failure as a result of taking Actos. Contact us for a free consultation. 803.252.4800

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Categories
Archives

Follow us

Sign Up For Our Newsletter!